KIN1148

Item number	Size	Manual	Delivery time	Price
TGM-T4027-1mg	1 mg	-	7 - 10 business days*	133.00€
TGM-T4027-2mg	2 mg	-	7 - 10 business days*	224.00€
TGM-T4027-1mL	1 ml	-	7 - 10 business days*	345.00€
TGM-T4027-5mg	5 mg	-	7 - 10 business days*	437.00€
TGM-T4027-10mg	10 mg	-	7 - 10 business days*	659.00€
TGM-T4027-25mg	25 mg	-	7 - 10 business days*	1,039.00€
TGM-T4027-50mg	50 mg	-	7 - 10 business days*	1,402.00€
TGM-T4027-100mg	100 mg	-	7 - 10 business days*	1,894.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and... more

Close menu

Product information "KIN1148"

Description: KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection. The adjuvant will be developed for an FDA-approved avian inluenza virus vaccine as well as evaluation in flavivirus vaccine platforms, including West Nile virus, because of the small molecules broad immune-enhancing activity. Target: Influenza Virus. Smiles: O=C(Nc1nc2ccc3scnc3c2s1)c1ccc2ccccc2c1. References: Probst P., et al. A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.

Supplier:	TargetMol
Supplier-Nr:	T4027

Properties

Application:	IRF3 activator, adjuvant
MW:	361.44 D
Formula:	C19H11N3OS2

Database Information

CAS :	1428729-56-9\| Matching products
KEGG ID :	K05411 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "KIN1148"

Write a review